My understanding was that the 'AI capable partner'
Post# of 148190
Quote:
My understanding was that the 'AI capable partner' was for the purpose of developing a longer term therapeutic for Leronlimab... (not to find more indications to pursue)
You are correct. I should have listened to the CC first. Extending patent protection would also have the benefit of assuring any partners of a long runway for the drug.